Minimally invasive spine surgery (MISS) has evolved significantly over the past 15 years, focusing on reducing collateral tissue damage while efficiently addressing various spinal pathologies. The techniques offer benefits such as less postoperative pain, reduced blood loss, and quicker recovery but also present challenges like a steeper learning curve and higher costs. A significant need remains for multicenter randomized controlled studies to better define the advantages and limitations of MISS in spinal surgery.